These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 37464337)

  • 21. Can Tramadol be Used for Maintenance Treatment of Opioid Dependence?
    Sarkar S; Lal R; Varshney M; Kumar S; Singh Balhara YP
    Subst Use Misuse; 2019; 54(3):506-513. PubMed ID: 30395757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic.
    Skurtveit S; Nechanská B; Handal M; Mahic M; Mravčík V; Gabrhelík R
    Addiction; 2019 Jul; 114(7):1225-1235. PubMed ID: 30725515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological therapies for management of opium withdrawal.
    Rahimi-Movaghar A; Gholami J; Amato L; Hoseinie L; Yousefi-Nooraie R; Amin-Esmaeili M
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007522. PubMed ID: 29929212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of Patients in Long-Term Opioid Maintenance Treatment.
    Zippel-Schultz B; Specka M; Cimander K; Eschenhagen T; Gölz J; Maryschok M; Nowak M; Poehlke T; Stöver H; Helms TM; Scherbaum N
    Subst Use Misuse; 2016 Sep; 51(11):1493-503. PubMed ID: 27355105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial.
    Ellerbroek H; van den Heuvel SAS; Dahan A; Timmerman H; Kramers C; Schellekens AFA
    Addict Sci Clin Pract; 2022 Sep; 17(1):47. PubMed ID: 36057608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a sequential multiple assignment randomized trial to test contingency management and an integrated behavioral economic and mindfulness intervention for buprenorphine-naloxone medication adherence for opioid use disorder.
    Peter SC; Murphy JG; Witkiewitz K; Hand SB; Thomas F; Johnson KC; Cowan R; Harris M; Derefinko KJ
    Trials; 2023 Mar; 24(1):237. PubMed ID: 36991453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opium tincture versus methadone for opioid agonist treatment: a randomized controlled trial.
    Nikoo M; Kianpoor K; Nikoo N; Javidanbardan S; Kazemi A; Choi F; Vogel M; Gholami A; Tavakoli S; Wong JSH; Moazen-Zadeh E; Givaki R; Jazani M; Mohammadian F; Moghaddam NM; Schütz C; Jang K; Akhondzadeh S; Krausz M
    Addiction; 2023 Feb; 118(2):284-294. PubMed ID: 35971297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with non-adherence and misuse of opioid maintenance treatment medications and intoxicating drugs among Finnish maintenance treatment patients.
    Launonen E; Wallace I; Kotovirta E; Alho H; Simojoki K
    Drug Alcohol Depend; 2016 May; 162():227-35. PubMed ID: 27068849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effectiveness of opioid maintenance treatment in prison settings: a systematic review.
    Hedrich D; Alves P; Farrell M; Stöver H; Møller L; Mayet S
    Addiction; 2012 Mar; 107(3):501-17. PubMed ID: 21955033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opium tincture-assisted treatment for opioid use disorder: A systematic review.
    Noroozi A; Kebriaeezadeh A; Mirrahimi B; Armoon B; Ahounbar E; Narenjiha H; Salehi M; Karamouzian M
    J Subst Abuse Treat; 2021 Oct; 129():108519. PubMed ID: 34119894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world use and clinical outcomes after 24 weeks of treatment with a prescription digital therapeutic for opioid use disorder.
    Maricich YA; Gerwien R; Kuo A; Malone DC; Velez FF
    Hosp Pract (1995); 2021 Dec; 49(5):348-355. PubMed ID: 34461801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment.
    Mokri A; Chawarski MC; Taherinakhost H; Schottenfeld RS
    Addiction; 2016 May; 111(5):874-82. PubMed ID: 26639678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of opioid maintenance treatment in prisons in North Rhine-Westphalia, Germany - a top down approach.
    Böhmer K; Schecke H; Render I; Scherbaum N
    Subst Abuse Treat Prev Policy; 2020 Mar; 15(1):21. PubMed ID: 32156295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder.
    Ober AJ; Murray-Krezan C; Page K; Friedmann PD; Chan Osilla K; Ryzewicz S; Huerta S; Mazer MW; Leamon I; Messineo G; Watkins KE; Nuckols T; Danovitch I
    Addict Sci Clin Pract; 2022 Jul; 17(1):39. PubMed ID: 35902888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A patient-centered nurse-supported primary care-based collaborative care program to treat opioid use disorder and depression: Design and protocol for the MI-CARE randomized controlled trial.
    DeBar LL; Bushey MA; Kroenke K; Bobb JF; Schoenbaum M; Thompson EE; Justice M; Zatzick D; Hamilton LK; McMullen CK; Hallgren KA; Benes LL; Forman DP; Caldeiro RM; Brown RP; Campbell NL; Anderson ML; Son S; Haggstrom DA; Whiteside L; Schleyer TKL; Bradley KA
    Contemp Clin Trials; 2023 Apr; 127():107124. PubMed ID: 36804450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder: protocol for a systematic review.
    Rice DB; Hutton B; Poulin P; Sproule BA; Wolfe D; Moher D; Thavorn K; Garber G; Taha S; Porath A; Willows M; Esmaeilisaraji L; Yazdi F; Shea B; Skidmore B; Corace K
    BMJ Open; 2018 Oct; 8(10):e023902. PubMed ID: 30341139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study protocol of the ESUB-MG cluster randomized trial: a pragmatic trial assessing the implementation of urine drug screening in general practice for buprenorphine maintained patients.
    ESUB-MG Study Group
    BMC Fam Pract; 2016 Mar; 17():24. PubMed ID: 26931763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years.
    Janssen E; Vuolo M; Spilka S; Airagnes G
    Harm Reduct J; 2024 Jan; 21(1):15. PubMed ID: 38243253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.
    Palis H; Marchand K; Guh D; Brissette S; Lock K; MacDonald S; Harrison S; Anis AH; Krausz M; Marsh DC; Schechter MT; Oviedo-Joekes E
    Subst Abuse Treat Prev Policy; 2017 May; 12(1):25. PubMed ID: 28526048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.